Jacobs Levy Equity Management, Inc Mei Pharma, Inc. Transaction History

Jacobs Levy Equity Management, Inc

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$0.42 - $0.65 $101,698 - $157,391	-242,140 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$0.54 - $2.74 $130,755 - $663,463	242,140 New	242,140 $146,000
Q2 2020 Aug 17, 2020	SELL	$1.45 - $4.3 $30,657 - $90,914	-21,143 Closed	0 $0
Q1 2020 May 15, 2020	SELL	$0.75 - $2.55 $145,649 - $495,207	-194,199 Reduced 90.18%	21,143 $34,000
Q4 2019 Feb 14, 2020	SELL	$1.65 - $2.48 $94,261 - $141,677	-57,128 Reduced 20.97%	215,342 $534,000
Q3 2019 Nov 14, 2019	BUY	$1.48 - $2.52 $202,680 - $345,103	136,946 Added 101.05%	272,470 $458,000
Q2 2019 Aug 13, 2019	BUY	$2.45 - $3.32 $290,043 - $393,038	118,385 Added 690.73%	135,524 $339,000
Q1 2019 May 14, 2019	SELL	$2.52 - $3.24 $67,881 - $87,275	-26,937 Reduced 61.11%	17,139 $53,000
Q4 2018 Feb 14, 2019	SELL	$1.92 - $4.1 $200,519 - $428,191	-104,437 Reduced 70.32%	44,076 $116,000
Q3 2018 Nov 14, 2018	BUY	$3.39 - $4.61 $118,727 - $161,456	35,023 Added 30.86%	148,513 $640,000
Q2 2018 Aug 14, 2018	SELL	$1.89 - $4.95 $132,218 - $346,287	-69,957 Reduced 38.13%	113,490 $447,000
Q1 2018 May 15, 2018	SELL	$2.06 - $2.38 $13,390 - $15,470	-6,500 Reduced 3.42%	183,447 $380,000
Q4 2017 Feb 13, 2018	BUY	$1.91 - $2.83 $5,500 - $8,150	2,880 Added 1.54%	189,947 $399,000
Q3 2017 Nov 14, 2017	BUY	$2.44 - $2.91 $215,639 - $257,177	88,377 Added 89.55%	187,067 $501,000
Q2 2017 Nov 09, 2017	BUY	N/A	98,690	98,690 $236,000

Ticker MEIP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 133,261,000
Market Cap $389M
Description
MEI Pharma, Inc., a late-stage pharmaceutical company, focuses on the development and commercialization of various therapies for the treatment of cancer. The company develops Zandelisib, an oral phosphatidylinositol 3-kinase delta inhibitor that is in Phase III clinical trial for the treatment of patients with relapsed/refractory follicular lymp...

Get notified when there are updates to the investment portfolio of Jacobs Levy Equity Management, Inc, based on Form 13F filings with the SEC.

Stay updated on Jacobs Levy Equity Management, Inc with notifications on news.